HOSPITAL UNIVERSITARIO QUIRÓNSALUD MADRID
Departamento
Charité
Berlín, AlemaniaPublicaciones en colaboración con investigadores/as de Charité (9)
2020
-
New Algorithms Improving PML Risk Stratification in MS Patients Treated With Natalizumab
Frontiers in Neurology, Vol. 11
2019
-
Exercise training for patients with type 2 diabetes and cardiovascular disease: What to pursue and how to do it. A Position Paper of the European Association of Preventive Cardiology (EAPC)
European Journal of Preventive Cardiology, Vol. 26, Núm. 7, pp. 709-727
-
Exercise training to reduce cardiovascular risk in patients with metabolic syndrome and type 2 diabetes mellitus: How does it work?
European Journal of Preventive Cardiology, Vol. 26, Núm. 7, pp. 701-708
2017
-
Brain tumors in eloquent areas: A European multicenter survey of intraoperative mapping techniques, intraoperative seizures occurrence, and antiepileptic drug prophylaxis
Neurosurgical Review, Vol. 40, Núm. 2, pp. 287-298
2015
-
Effects of diazoxide in multiple sclerosis: A randomized, double-blind phase 2 clinical trial
Neurology: Neuroimmunology and NeuroInflammation, Vol. 2, Núm. 5, pp. e147
-
Genome-wide significant association with seven novel multiple sclerosis risk loci
Journal of Medical Genetics, Vol. 52, Núm. 12, pp. 848-855
2013
-
MANBA, CXCR5, SOX8, RPS6KB1 and ZBTB46 are genetic risk loci for multiple sclerosis
Brain, Vol. 136, Núm. 6, pp. 1778-1782
-
Treatment of idiopathic pulmonary fibrosis with Ambrisentan: A parallel, randomized trial
Annals of Internal Medicine, Vol. 158, Núm. 9, pp. 641-649
2012
-
Closing the case of APOE in multiple sclerosis: No association with disease risk in over 29 000 subjects
Journal of Medical Genetics, Vol. 49, Núm. 9, pp. 558-562